T1	Participants 74 86	osteoporosis
T2	Participants 146 158	osteoporosis
T3	Participants 407 419	multi-center
T4	Participants 478 653	Consecutive post-menopausal women aged 50 years to 86 years starting treatment with raloxifene according to daily practice were enrolled from 126 primary care offices in Spain
T5	Participants 942 1028	745 post-menopausal women (group A, n=366; group B n=379), with a mean age of 62 years
T6	Participants 1701 1751	young post-menopausal women suffering osteoporosis
